Agios Pharmaceuticals | ApexOnco - Clinical Trials news and analysis

x

“Top quality, fast and so easy to use”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Data insights Regulatory

8 August 2024

The month ahead: August’s remaining events

Following its odronextamab knockback, Regeneron now faces a delay to linvoseltamab.

Subscribe to Agios Pharmaceuticals